Uncharacterized Protein, Uncharacterized
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 9 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 | 
| NetGPI | no | yes: 0, no: 11 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 140 | 144 | PF00656 | 0.352 | 
| CLV_C14_Caspase3-7 | 262 | 266 | PF00656 | 0.514 | 
| CLV_C14_Caspase3-7 | 91 | 95 | PF00656 | 0.515 | 
| CLV_NRD_NRD_1 | 259 | 261 | PF00675 | 0.372 | 
| CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.375 | 
| CLV_PCSK_KEX2_1 | 191 | 193 | PF00082 | 0.553 | 
| CLV_PCSK_KEX2_1 | 259 | 261 | PF00082 | 0.372 | 
| CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.358 | 
| CLV_PCSK_PC1ET2_1 | 191 | 193 | PF00082 | 0.394 | 
| CLV_PCSK_PC7_1 | 255 | 261 | PF00082 | 0.354 | 
| CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.345 | 
| CLV_PCSK_SKI1_1 | 62 | 66 | PF00082 | 0.468 | 
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.520 | 
| DOC_CYCLIN_yCln2_LP_2 | 38 | 44 | PF00134 | 0.446 | 
| DOC_MAPK_gen_1 | 11 | 19 | PF00069 | 0.370 | 
| DOC_MAPK_gen_1 | 26 | 34 | PF00069 | 0.264 | 
| DOC_MAPK_MEF2A_6 | 110 | 118 | PF00069 | 0.426 | 
| DOC_PP4_FxxP_1 | 131 | 134 | PF00568 | 0.310 | 
| DOC_PP4_FxxP_1 | 286 | 289 | PF00568 | 0.379 | 
| DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.550 | 
| DOC_USP7_MATH_1 | 269 | 273 | PF00917 | 0.407 | 
| DOC_WW_Pin1_4 | 199 | 204 | PF00397 | 0.347 | 
| DOC_WW_Pin1_4 | 273 | 278 | PF00397 | 0.368 | 
| DOC_WW_Pin1_4 | 83 | 88 | PF00397 | 0.636 | 
| LIG_14-3-3_CanoR_1 | 241 | 249 | PF00244 | 0.327 | 
| LIG_14-3-3_CanoR_1 | 3 | 9 | PF00244 | 0.468 | 
| LIG_BRCT_BRCA1_1 | 4 | 8 | PF00533 | 0.502 | 
| LIG_FHA_1 | 225 | 231 | PF00498 | 0.349 | 
| LIG_FHA_1 | 43 | 49 | PF00498 | 0.338 | 
| LIG_FHA_1 | 59 | 65 | PF00498 | 0.351 | 
| LIG_FHA_1 | 84 | 90 | PF00498 | 0.726 | 
| LIG_FHA_2 | 138 | 144 | PF00498 | 0.450 | 
| LIG_LIR_Apic_2 | 283 | 289 | PF02991 | 0.395 | 
| LIG_LIR_Apic_2 | 71 | 77 | PF02991 | 0.374 | 
| LIG_LIR_Gen_1 | 159 | 169 | PF02991 | 0.346 | 
| LIG_LIR_Nem_3 | 159 | 164 | PF02991 | 0.338 | 
| LIG_LIR_Nem_3 | 227 | 232 | PF02991 | 0.519 | 
| LIG_LRP6_Inhibitor_1 | 104 | 110 | PF00058 | 0.384 | 
| LIG_PTB_Apo_2 | 125 | 132 | PF02174 | 0.297 | 
| LIG_SH2_CRK | 171 | 175 | PF00017 | 0.367 | 
| LIG_SH2_CRK | 74 | 78 | PF00017 | 0.455 | 
| LIG_SH2_NCK_1 | 74 | 78 | PF00017 | 0.464 | 
| LIG_SH2_STAT5 | 117 | 120 | PF00017 | 0.312 | 
| LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.309 | 
| LIG_SH2_STAT5 | 248 | 251 | PF00017 | 0.338 | 
| LIG_SH3_3 | 123 | 129 | PF00018 | 0.309 | 
| LIG_SH3_3 | 200 | 206 | PF00018 | 0.343 | 
| LIG_SH3_3 | 38 | 44 | PF00018 | 0.458 | 
| LIG_TYR_ITIM | 169 | 174 | PF00017 | 0.347 | 
| MOD_CK1_1 | 243 | 249 | PF00069 | 0.416 | 
| MOD_CK2_1 | 139 | 145 | PF00069 | 0.487 | 
| MOD_CK2_1 | 175 | 181 | PF00069 | 0.501 | 
| MOD_GlcNHglycan | 235 | 238 | PF01048 | 0.358 | 
| MOD_GSK3_1 | 269 | 276 | PF00069 | 0.355 | 
| MOD_GSK3_1 | 58 | 65 | PF00069 | 0.421 | 
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.507 | 
| MOD_NEK2_1 | 116 | 121 | PF00069 | 0.314 | 
| MOD_NEK2_1 | 169 | 174 | PF00069 | 0.406 | 
| MOD_NEK2_2 | 254 | 259 | PF00069 | 0.347 | 
| MOD_PIKK_1 | 137 | 143 | PF00454 | 0.516 | 
| MOD_PIKK_1 | 235 | 241 | PF00454 | 0.358 | 
| MOD_PKA_2 | 2 | 8 | PF00069 | 0.425 | 
| MOD_PKA_2 | 240 | 246 | PF00069 | 0.335 | 
| MOD_PKA_2 | 254 | 260 | PF00069 | 0.360 | 
| MOD_PKA_2 | 28 | 34 | PF00069 | 0.381 | 
| MOD_PKA_2 | 81 | 87 | PF00069 | 0.607 | 
| MOD_Plk_1 | 282 | 288 | PF00069 | 0.479 | 
| MOD_Plk_4 | 156 | 162 | PF00069 | 0.346 | 
| MOD_Plk_4 | 43 | 49 | PF00069 | 0.296 | 
| MOD_ProDKin_1 | 199 | 205 | PF00069 | 0.345 | 
| MOD_ProDKin_1 | 273 | 279 | PF00069 | 0.364 | 
| MOD_ProDKin_1 | 83 | 89 | PF00069 | 0.637 | 
| TRG_DiLeu_BaLyEn_6 | 38 | 43 | PF01217 | 0.437 | 
| TRG_DiLeu_BaLyEn_6 | 59 | 64 | PF01217 | 0.482 | 
| TRG_ENDOCYTIC_2 | 161 | 164 | PF00928 | 0.379 | 
| TRG_ENDOCYTIC_2 | 171 | 174 | PF00928 | 0.323 | 
| TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.330 | 
| TRG_ENDOCYTIC_2 | 214 | 217 | PF00928 | 0.365 | 
| TRG_ER_diArg_1 | 211 | 214 | PF00400 | 0.368 | 
| TRG_ER_diArg_1 | 258 | 260 | PF00400 | 0.362 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N0P378 | Leptomonas seymouri | 81% | 100% | 
| A0A0S4JD50 | Bodo saltans | 57% | 100% | 
| A0A1X0P6P5 | Trypanosomatidae | 71% | 100% | 
| A0A3S7X993 | Leishmania donovani | 99% | 100% | 
| A0A422MYC0 | Trypanosoma rangeli | 67% | 100% | 
| A4HMP6 | Leishmania braziliensis | 92% | 100% | 
| C9ZZD8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 99% | 
| E9AF47 | Leishmania major | 96% | 100% | 
| E9B6A3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% | 
| V5BTH8 | Trypanosoma cruzi | 69% | 100% |